/var/www/vhosts/wisconsindiagnostic.com/htdocs/assets/common.php on line 15
/assets/images/logo_social.png" />
Dr. Pant’s responsibilities include include gastrointestinal and liver pathology. She is actively involved in teaching medical students, residents, and the GI pathology fellow.
Chang JC, Harrington AM, Olteanu H, VanTuinen P, Kroft SH.
Proliferation centers in bone marrows involved by chronic lymphocytic leukemia/small lymphocytic lymphoma: a clinicopathologic analysis.Ann Diagn Pathol 2016 Dec;25:15-19
Harrington AM, Schelling LA, Ordobazari A, Olteanu H, Hosking PR, Kroft SH.
Immunophenotypes of Chronic Myelomonocytic Leukemia (CMML) Subtypes by Flow Cytometry: A Comparison of CMML-1 vs CMML-2, Myeloproliferative vs Dysplastic, De Novo vs Therapy-Related, and CMML-Specific Cytogenetic Risk Subtypes.Am J Clin Pathol 2016 Aug;146(2):170-81
Li H, Hasserjian RP, Kroft SH, Harrington AM, Wheaton SE, Pildain A, Ewalt MD, Gratzinger D, Hosking P, Olteanu H.
Pure Erythroid Leukemia and Erythroblastic Sarcoma Evolving From Chronic Myeloid Neoplasms.Am J Clin Pathol 2016 Apr;145(4):538-51
Nelson AA, Harrington AM, Kroft S, Dahar MA, Hamadani M, Dhakal B.
Presentation and management of post-allogeneic transplantation EBV-positive mucocutaneous ulcer.Bone Marrow Transplant 2016 Feb;51(2):300-2
Cogbill CH, Spears MD, Vantuinen P, Harrington AM, Olteanu H, Kroft SH.
Morphologic and cytogenetic variables affect the flow cytometric recovery of plasma cell myeloma cells in bone marrow aspirates.Int J Lab Hematol 2015 Dec;37(6):797-808
Olteanu H, Harrington AM, Kroft SH.
CD200 expression in plasma cells of nonmyeloma immunoproliferative disorders: clinicopathologic features and comparison with plasma cell myeloma.Am J Clin Pathol 2012 ;2(2):128-35